Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 3 of 25, showing 10 Applications out of 243 total, starting on record 21, ending on 30

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

21.

ECCT/25/08/05   Floral roll over study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study.   
Principal Investigator(s)
1. Dr. Isaac Tsikhutsu
Site(s) in Kenya
1. KEMRI WALTER REED KERICHO (Kericho county)
2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrudes Childrens Hospital (Nairobi City county)
5. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
6. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
7. KEMRI Kondele Children\'s Hospital (Kisumu county)
 
09-02-2026 View

22.

ECCT/25/08/04   MK-8527-010 PrEP
    A Phase 3, Randomized, Active-Controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 Once-Monthly as HIV-1 Preexposure Prophylaxis in Cisgender Women    
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. KEMRI-CCR PHRD Thika (Kiambu county)
 
25-11-2025 View

23.

ECCT/25/08/02   MK-8527-010
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women.   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
1. KEMRI CMR RCTP (Kisumu county)
 
21-11-2025 View

24.

ECCT/25/08/01   MK-8527 as HIV-1 PrEP in Women
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure   Prophylaxis in Women       
Principal Investigator(s)
1. Maricianah Onono
Site(s) in Kenya
1. KEMRI-RCTP KISUMU (Kisumu county)
2. Kargeno Research and Policy Hub KEMRI-CMR KISUMU (Kisumu county)
3. KEMRI-PHRD, Thika (Kiambu county)
4. UW KNH - Rachuonyo County Hospital (Homa Bay county)
 
21-11-2025 View

25.

ECCT/25/07/08   REACH
    Heat-stable carbetocin for the treatment of postpartum haemorrhage: a phase III, randomized, double-blind, active controlled, multicountry, multicentre,   non-inferiority trial   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Machakos county hospital (Machakos county)
2. Pumwani maternity hospital (Nairobi City county)
3. Nakuru Level 5 Hospital (Nakuru county)
 
17-12-2025 View

26.

ECCT/25/07/04   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Mourine Ikol
Site(s) in Kenya
1. Kisii Teaching and Referral Hospital (Kisii county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Migori County Referral Hospital (Migori county)
 
20-04-2026 View

27.

ECCT/25/07/03   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   
Principal Investigator(s)
1. Joyce Akuka
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Kisii Teaching and Referral Hospital (Kisii county)
 
14-04-2026 View

28.

ECCT/25/07/02   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Meshack Liru
Site(s) in Kenya
1. Homabay County Referral Hospital (Homa Bay county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisii Teaching and Referral Hospital (Kisii county)
4. Migori County Referral Hospital (Migori county)
 
14-04-2026 View

29.

ECCT/25/06/02   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Nayirat Mohamed Dormohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
02-10-2025 View

30.

ECCT/25/06/01   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christine Nafula Manyasi
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
02-10-2025 View